吡咯喹啉醌 (PQQ) Pyrroloquinoline Quinone (PQQ) × 老化

結論:證據分歧

PQQ × 老化的人體證據實質上仍處臨床前/前導試驗階段:僅 1 篇 6 週、n=34 的 MCI 高齡者 RCT(非一般 aging 族群),且作者具 CalerieLife 補充劑商諮詢費 COI;無任何 MA/SR;動物資料雖一致正向(骨/椎間盤/肌少/免疫/SASP,2023–2025),但分別來自 Mitsubishi Gas Chemical 全額資助與 BY-HEALTH 合作的研究,工業 COI 滲透嚴重;機轉(Nrf2/PGC-1α/SIRT1/senomorphic)合理但屬 surrogate marker,rodent healthspan→human aging 的歷史轉譯失敗率高(resveratrol、NR 前例)。

C 🟠 C 薄弱證據 證據分歧 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 💊 檢驗 / 藥物交互作用

PQQ × 老化的人體證據實質上仍處臨床前/前導試驗階段:僅 1 篇 6 週、n=34 的 MCI 高齡者 RCT(非一般 aging 族群),且作者具 CalerieLife 補充劑商諮詢費 COI;無任何 MA/SR;動物資料雖一致正向(骨/椎間盤/肌少/免疫/SASP,2023–2025),但分別來自 Mitsubishi Gas Chemical 全額資助與 BY-HEALTH 合作的研究,工業 COI 滲透嚴重;機轉(Nrf2/PGC-1α/SIRT1/senomorphic)合理但屬 surrogate marker,rodent healthspan→human aging 的歷史轉譯失敗率高(resveratrol、NR 前例)。

Examine 在 aging 與 cognitive function 兩個條件下皆 found_in_examine=false,僅在 fatigue 給予 D 級且 condition-related fatigue 直接「No effect」——這與一般市場將 PQQ 包裝為粒線體抗老化神器的敘事直接矛盾。

GSA/NIA/AFAR/AGS 四大老化權威全部 not_addressed 或僅引用 NIA 抗老化補充劑通則性警示;Mayo/Cleveland/Harvard 三大臨床機構均無 PQQ 專屬內容。

獨立判讀對齊 Tier C(薄弱證據):機轉合理 + 少量人體研究 + 學會「insufficient evidence」立場,遠未到 Tier B 的「方向一致小型 RCT」門檻(因為只有 1 篇且非 aging endpoint)。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.55
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 證據分歧
信心度
69%
證據方向大致一致
證據層級
E7
單篇小型隨機對照試驗

各層「支持此療效」的程度

分數越低=該層越不支持
L5 臨床機構權威立場
0.40
L1 Examine國際基準
0.50
L3 機轉生理合理性
0.50
L11 AI 複核獨立判讀
0.50
L2 PubMed原始文獻
0.75
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.55
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Six-week dihydrogen-PQQ supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly MCI
PMID: 38908296 2024 RCT (double-blind) n = 34
結論:BDNF +14.4% in PQQ arm (p=0.01); ADAS-Cog orientation +22.2% vs placebo (p=0.03); cerebral oxygen saturation 48.4%->52.8% (p=0.005); NAA increased at 7/13 brain locations (p<=0.05). Positive but small pilot, short duration.
學術資助
前往 PubMed
PQQ Reprograms Single-Cell Landscape of Immune Aging in Hematopoietic Immune System
PMID: 40192736 2025 Animal Study n = 5
結論:PQQ reduced blood inflammatory factors (TNF-alpha, CCL4) in aged mice; scRNA-seq showed reduced oxidative stress across HIS cell types; identified ASPP1, Yy1, CD62L as molecular mediators; senolytic and senomorphic effects demonstrated. p-values reported as significant across endpoints.
學術資助
前往 PubMed
PQQ is an Effective Senomorphic Agent Targeting Pro-Inflammatory SASP
PMID: 40538098 2025 Animal Study
結論:PQQ downregulated core SASP factors at 100 microM (p<0.001) without affecting senescence markers (selective senomorphic, not senolytic in vitro). In aged mice: significant SASP reduction in liver/kidney/spleen (p<0.05 to p<0.0001), F4/80+ macrophages reduced (p<0.01). HSPA8 identified as direct target.
🟢 高品質 混合資助
前往 PubMed
PQQ alleviates natural aging-related osteoporosis via MCM3-Keap1-Nrf2 axis and Fbn1 upregulation
PMID: 37365714 2023 Animal Study
結論:PQQ prevented age-related bone loss via dual mechanism (inhibits osteoclasts + stimulates osteoblasts); Nrf2 KO blunted effect, confirming Nrf2-dependent mechanism; Fbn1 upregulation reduced RANKL in aged osteoblasts (p<0.05 to p<0.001).
🟢 高品質 學術資助
前往 PubMed
Dietary PQQ hinders aging progression in male mice and D-galactose-induced cells
PMID: 38487591 2024 Animal Study n = 6
結論:PQQ prevented rapid fat loss and fluid accumulation; attenuated fast-twitch muscle fiber atrophy (p=0.020); reduced IL-6, TNF-alpha; improved hanging test strength; enhanced mitochondrial function and reduced ROS in cell models.
⚠️ 廠商資助
前往 PubMed

L4a US FDA
支持
FDA has no questions at this time regarding [the notifier's] conclusion that pyrroloquinoline quinone (PQQ) disodium salt is GRAS under the intended conditions of use. 來源↗
L4b EU EFSA
中性
The Panel concludes that the NF, pyrroloquinoline quinone disodium salt (BioPQQ™), is safe under the intended conditions of use as specified by the applicant. 來源↗
L4c UK NHS
未表態
Food Supplements as defined in Directive 2002/46/EC intended for the adult population, excluding pregnant and lactating women. ... This food supplement should be consumed by adults only excluding pregnant and lactating women. 來源↗
L4d TW TFDA / 衛福部
謹慎
— 本適應症無對應資料
L4e WHO
支持
Pyrroloquinoline quinone disodium salt produced by fermentation using Hyphomicrobium denitrificans CK-275 is safe under the intended conditions of use. The applicant intends to market PQQ for use in food supplements for healthy adults, except pregnant and lactating women, at a maximum proposed level of consumption of 20 mg/day (corresponding to 0.29 mg/kg bw per day for a 70-kg person). 來源↗

L5a NIH Office of Dietary Supplements
未表態
— 本適應症無對應資料
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
未表態
— 本適應症無對應資料
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
謹慎
Some advertisements for dietary supplements promise that some of these products will make you feel better, keep you from getting sick, or even help you live longer. It's important to know that often, there is little, if any, science supporting these claims. 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

台灣社群(PTT 健身/保健、Dcard、Mobile01)幾乎無 PQQ 用於抗老的真實鄉民實測討論。PTT MuscleBeach 補劑討論串多聚焦乳清、肌酸、魚油、Q10,未見 PQQ。中文相關內容以業配部落格、保健品電商與痞客邦藥師衛教文為主,缺乏匿名辯證式社群心得。

💬社群實感

無共識

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

California Gold PQQ 20mg 60粒 $473

代表來源 ↗
L10b · TFDA 法定身份 官方認定
🍽️一般食品

食品不得宣稱醫療效能

來源 ↗

  • 規律身體活動(有氧、肌力與平衡訓練)
  • 戒菸
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 5 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v6 engine_version: v1.0 claim_id: CLM-COND-aging-INT-pyrroloquinoline-quinone-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-aging-INT-pyrroloquinoline-quinone-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "吡咯喹啉醌 (PQQ)能改善老化",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}